Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Concerned By Confusion Over OTC Drug Brands, US FDA Offers Guidance On Developing Names

Dec 09 2020

• By Eileen Francis

Related Content

Draft Guidance On Developing Drug Names Calls For Simulation Studies

Jun 02 2014

OTC Umbrella Branding Soaked By Regulatory Storm In Draft Guidance – CHPA

Oct 01 2014

Additional Topics

International United States OTC Drugs Guidance Documents FDA Commercial Compliance Drug Approval Standards Ingredients Manufacturing Policy Regulation Consumer

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window